These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 21880832)
41. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats. Naelten G; Liu KL; Chapuis B; Lo M Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554 [TBL] [Abstract][Full Text] [Related]
42. [Pronounced homeostatic action of angiotensin converting enzyme inhibitors with high affinity to tissue renin-angiotensin-aldosterone system on cellular membranes]. Inzhutova AI; Salmina AB; Petrova MM Kardiologiia; 2007; 47(8):49-52. PubMed ID: 18260912 [TBL] [Abstract][Full Text] [Related]
43. Improvement of impaired coronary vasodilator reserve in hypertensive patients by low-dose ACE inhibitor/diuretic therapy: a pilot PET study. Mourad JJ; Hanon O; Deverre JR; Camici PG; Sellier P; Duboc D; Safar ME J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):94-5. PubMed ID: 12806590 [No Abstract] [Full Text] [Related]
45. Effect of perindopril on renal medullary blood flow: comparison with other antihypertensive treatments. Issiakhem M; Liu KL; Benzoni D J Cardiovasc Pharmacol; 2008 Mar; 51(3):280-5. PubMed ID: 18356693 [TBL] [Abstract][Full Text] [Related]
46. Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes. Erensoy N; Yilmazer S; Oztürk M; Tunçdemir M; Uysal O; Hatemi H Acta Histochem; 2004; 106(4):279-87. PubMed ID: 15350810 [TBL] [Abstract][Full Text] [Related]
47. The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial. Brugts JJ; Boersma E; Chonchol M; Deckers JW; Bertrand M; Remme WJ; Ferrari R; Fox K; Simoons ML; J Am Coll Cardiol; 2007 Nov; 50(22):2148-55. PubMed ID: 18036453 [TBL] [Abstract][Full Text] [Related]
48. Perindopril versus angiotensin II receptor blockade in hypertension and coronary artery disease: implications of clinical trials. Brady AJ Clin Drug Investig; 2007; 27(3):149-61. PubMed ID: 17305412 [TBL] [Abstract][Full Text] [Related]
49. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels. Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017 [TBL] [Abstract][Full Text] [Related]
50. Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats? Bahi L; Koulmann N; Sanchez H; Momken I; Veksler V; Bigard AX; Ventura-Clapier R J Appl Physiol (1985); 2004 Jan; 96(1):59-64. PubMed ID: 12949022 [TBL] [Abstract][Full Text] [Related]
51. [Dynamic results of the EUROPA study: mechanisms of a favourable influence of perindopril on the course of IHD and decreased IHD mortality]. Eliseev OM Ter Arkh; 2005; 77(2):83-5. PubMed ID: 15807463 [No Abstract] [Full Text] [Related]
52. High affinity binding sites for Perindopril a new inhibitor of angiotensin-I-converting enzyme (ACE) in the rabbit kidney: possible evidence for localization of ACE in endothelial structures and in glomerular mesangium. Morin JP; Moulin B; Borghi H; Fillastre JP Int J Tissue React; 1989; 11(2):81-92. PubMed ID: 2559047 [TBL] [Abstract][Full Text] [Related]